| Bioptix, Inc.                                      |
|----------------------------------------------------|
| (Exact name of registrant as specified in charter) |
| Colorado                                                       | 84-1553387                        |
|----------------------------------------------------------------|-----------------------------------|
| (State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
| 834-F South Perry Street, Suite 443Castle Rock, CO | 80104      |
|----------------------------------------------------|------------|
| (Address of principal executive offices)           | (Zip Code) |
| Title of Each Class        | Name of each exchange on which registered |
|----------------------------|-------------------------------------------|
| Common Stock, No Par Value | NASDAQ Capital Market                     |

----

|   | Large accelerated filer ☐ Non-accelerated filer ☐(Do not check if smaller reporting company) | Accelerated filer ☐ Smaller reporting company ☒ Emerging growth company ☐ |
|--------|-------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|

----

----

----

| PART III |                                                                                            |
|----------|-------------------------------------------------------------------------------------------------|
|     |                                                                                            |   |
| Item 10. | Directors, Executive Officers and Corporate Governance.                                         | 2 |
| Item 11. | Executive Compensation.                                                                         | 7 |
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. | 12 |
| Item 13. | Certain Relationships and Related Transactions, and Director Independence.                      | 15 |
| Item 14. | Principal Accountant Fees and Services.                                                         | 15 |
|     |                                                                                            |   |
| PART IV  |                                                                                            |
|     |                                                                                            |   |
| Item 15. | Exhibits, Financial Statement Schedules.                                                        | 16 |

----

| Name                 |   | Age    |   | Position                                     |
|----------------------|--------|--------|--------|----------------------------------------------|
|                 |   |   |   |                                         |
| Michael M. Beeghley  |   | 50     |   | Chief Executive Officer and Chairman         |
| Mike Dai             |   | 30     |   | Director                                     |
| John O'Rourke        |   | 31     |   | Director                                     |
| Jeffrey G. McGonegal |   | 66     |   | Chief Financial Officer and Secretary        |
| Richard J. Whitcomb  |   | 56     |   | Senior Vice President, Corporate Development |

----

----

----

----

----

| Named Executive Officer and Principal Position |  Year |    | Salary($) |    | Option Awards(3)($) |      | Non-Equity Incentive Plan Compensation(4)($) |   | All OtherCompensation($) |   | Total($) |
|------------------------------------------------|------------|---------|-----------|---------|---------------------|-----------|----------------------------------------------|--------|--------------------------|--------|----------|
|                                           |       |    |      |    |                |      |                                         |   |                     |   |     |   |
| Stephen T. Lundy,                              | 2016       | 382,525 | 183,273   | 191,263 | 61,098              | 818,159   |
| Chief Executive Officer and President (1)      | 2015       | 382,525 | 572,670   | 154,951 | 44,006              | 1,154,152 |
|                                           |       |    |      |    |                |      |
| Jeffrey G. McGonegal,                          | 2016       | 272,005 | 89,506    | 136,003 | 16,111              | 513,625   |
| Chief Financial Officer (2)                    | 2015       | 272,005 | 279,720   | 85,682  | 13,800              | 651.207   |

----

|                           |   | Option Awards                                                      |   |
|--------------------------------|--------|--------------------------------------------------------------------|--------|
| Named Executive Officer        |   | Number of Securities Underlying Unexercised Options Exercisable(#) |   |   | Number of Securities Underlying Unexercised Options Unexercisable(#) |   |   | Equity IncentivePlan Awards:Number of Securities Underlying Unexercised Unearned Options (#) |   |   | OptionExercisePrice($) |   |   | OptionExpirationDate |   |
|                           |   |                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Stephen T. Lundy (1)           |   |                                                               | 883    |   |   |   | - |   |   |   | - |   |   |   | 547.20 |   |   |   | 3-24-2020 |   |
|                           |   |                                                               | 260    |   |   |   | - |   |   |   | - |   |   |   | 141.60 |   |   |   | 1-5-2021 |   |
|                           |   |                                                               | 1,400  |   |   |   | - |   |   |   | - |   |   |   | 163.20 |   |   |   | 7-8-2021 |   |
|                           |   |                                                               | 1,563  |   |   |   | - |   |   |   | - |   |   |   | 31.68 |   |   |   | 4-30-2022 |   |
|                           |   |                                                               | 12,417 |   |   |   | - |   |   |   | - |   |   |   | 16.80 |   |   |   | 12-11-2022 |   |
|                           |   |                                                               | 17,125 |   |   |   | - |   |   |   | - |   |   |   | 16.32 |   |   |   | 1-23-2023 |   |
|                           |   |                                                               | 22,250 |   |   |   | - |   |   |   | - |   |   |   | 18.16 |   |   |   | 1-06-2024 |   |
|                           |   |                                                               | 34,720 |   |   |   | 3,155 |   |   |   | - |   |   |   | 15.12 |   |   |   | 1-12-2025 |   |
|                           |   |                                                               | 43,000 |   |   |   | 43,000 |   |   |   |   |   |   |   | 2.89 |   |   |   | 5-9-2026 |   |
|                           |   |                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|  Jeffrey G. McGonegal (2) |   |                                                               | 209    |   |   |   | - |   |   |   | - |   |   |   | 710.40 |   |   |   | 1-24-2017 |   |
|                           |   |                                                               | 167    |   |   |   | - |   |   |   | - |   |   |   | 1,591.20 |   |   |   | 1-17-2018 |   |
|                           |   |                                                               | 209    |   |   |   | - |   |   |   | - |   |   |   | 319.20 |   |   |   | 1-27-2019 |   |
|                           |   |                                                               | 209    |   |   |   | - |   |   |   | - |   |   |   | 528.00 |   |   |   | 1-19-2020 |   |
|                           |   |                                                               | 209    |   |   |   | - |   |   |   | - |   |   |   | 141.60 |   |   |   | 1-5-2021 |   |
|                           |   |                                                               | 834    |   |   |   | - |   |   |   | - |   |   |   | 31.68 |   |   |   | 4-30-2022 |   |
|                           |   |                                                               | 6,585  |   |   |   | - |   |   |   | - |   |   |   | 16.80 |   |   |   | 12-11-2022 |   |
|                           |   |                                                               | 8,375  |   |   |   | - |   |   |   | - |   |   |   | 16.32 |   |   |   | 1-23-2023 |   |
|                           |   |                                                               | 10,875 |   |   |   | - |   |   |   | - |   |   |   | 18.16 |   |   |   | 1-06-2024 |   |
|                           |   |                                                               | 16,959 |   |   |   | 1,541 |   |   |   | - |   |   |   | 15.12 |   |   |   | 1-12-2025 |   |
|                           |   |                                                               | 21,000 |   |   |   | 21,000 |   |   |   |   |   |   |   | 2.89 |   |   |   | 5-9-2016 |   |

----

----

| Named Executive Officer |   | Benefit   |   | Terminationwithout Cause($) |   | Death orDisability($) |   | Change In Control(Single Trigger)($)  (1) |   | Change In Control(Double Trigger)($) |
|-------------------------|--------|-----------|--------|-----------------------------|--------|-----------------------|--------|------------------------------------------------|--------|--------------------------------------|
|                    |   |      |   |                        |   |                  |   |                                           |   |                                 |
| Stephen T. Lundy (2)    |   | Severance |   | 382,525                     |   | 95,631                |   | -                                              |   | 382,525                              |
|                    |   | Options   |   | -                           |   | -                     |   | 81,700                                         |   | 81,700                               |
|                    |   | Total     |   | 382,525                     |   | 95,631                |   | 81,700                                         |   | 469,625                              |
|                    |   |      |   |                        |   |                  |   |                                           |   |                                 |
| Jeffrey G. McGonegal    |   | Severance |   | 136,002                     |   | 136,002               |   | -                                              |   | 136,002                              |
|                    |   | Options   |   | -                           |   | -                     |   | 19,950                                         |   | 19,950                               |
|                    |   | Total     |   | 136,002                     |   | 136,002               |   | 19,950                                         |   | 155,952                              |
| Name                    |   | CashFees($) |   |   | OptionAwards($) (6) |   |   | Total($) |   |
|-------------------------|--------|-------------|--------|--------|---------------------|--------|--------|----------|--------|
|                    |   |        |   |   |                |   |   |     |   |
| Gail Schoettler (1)     |   |        | 24,000 |   |                |   | 44,753 |     |   |   | 68,753 |   |
| Michael M. Beeghley (2) |   |        | 1,000  |   |                |   | 36,717 |     |   |   | 37,717 |   |
| David Welch  (3)   |   |        | 12,000 |   |                |   | 29,835 |     |   |   | 41,835 |   |
| Susan Evans (4)         |   |        | 12,000 |   |                |   | 29,835 |     |   |   | 41,835 |   |
| Michael W. Routh (5)    |   |        | 1,000  |   |                |   | 36,717 |     |   |   | 37,717 |   |

----

----

| Name and Address                                      |   | Number of Shares |    |   | Percent |   |
|-------------------------------------------------------|--------|------------------|---------|--------|---------|--------|
| Directors:                                            |   |             |    |   |    |   |
|   Michael M. Beeghley (1)                   |   |             | 14,000  |   |    |   | * |   |
|   John R. O'Rourke (2)                      |   |             | 29,133  |   |    |   | * |   |
|   Mike Dai (3)                              |   |             | 3,333   |   |    |   | * |   |
| Other Executive Officers:                             |   |             |    |   |    |   |   |   |
|   Jeffrey G. McGonegal (4)                  |   |             | 89,244  |   |    |   | 1.9 | % |
|   Richard J. Whitcomb (5)                   |   |             | 20,405  |   |    |   | * |   |
| All Directors and Officers as a Group (5 persons) (6) |   |             | 156,115 |   |    |   | 3.4 | % |
| More than 5% Shareholders:                            |   |             |    |   |    |   |   |   |
|   Barry C. Honig (7)                        |   |             | 504,000 |   |    |   | 11.2 | % |
|   Catherine Johanna DeFrancesco (8)         |   |             | 515,777 |   |    |   | 11.5 | % |
|   E. Jeffrey Peierls (9)                    |   |             | 357,744 |   |    |   | 7.9 | % |
|                                                  |   |             |    |   |    |   |   |   |
|   |                                                                                                                                                                                                                                                                                                                                                                             |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)    | Includes options currently exercisable or exercisable within 60 days to purchase an aggregate of 2,333 shares at an exercise price of $3.00 per share. Includes a restricted stock award under the Bioptix, Inc. Amended & Restated Equity Incentive Plan, of which 11,667 shares have vested.                                                                               |
| (2)    | Includes an aggregate of 23,300 shares held by ATG Capital LLC ("ATG"). Mr. O'Rourke is the managing member and sole beneficiary of ATG and in such capacity holds voting and dispositive power over the securities held by ATG. Includes a restricted stock award under the Bioptix, Inc. Amended & Restated Equity Incentive Plan, of which 5,833 shares have vested. |

----

| (3) | Includes a restricted stock award under the Bioptix, Inc. Amended & Restated Equity Incentive Plan, of which 3,333 has vested.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4) | Includes 1,009 shares directly owned and 63 shares held in Mr. McGonegal's IRA. Includes options currently exercisable or exercisable within 60 days to purchase an aggregate of 88,172 shares at exercise prices ranging from $2.89 per share to $1,591.20 per share.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| (5) | Includes options currently exercisable or exercisable within 60 days to purchase an aggregate of 20,405 shares at an exercise price of $3.78 per share.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| (6) | Includes the information in footnotes (1) through (6).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| (7) | Includes (i) 29,815 shares of common stock, (ii) 443,585 shares of common stock held by GRQ Consultants, Inc. 401K ("401K") and (iii) 30,600 shares of common stock held by GRQ Consultants, Inc. Roth 401K FBO Barry Honig ("Roth 401K"). Mr. Honig is the trustee of 401K and Roth 401K in such capacity holds voting and dispositive power over the securities held by such entities.  Does not include (i) 200,000 shares of common stock issuable upon exercise of outstanding warrants held by Mr. Honig, (ii) shares of common stock issuable upon conversion of outstanding convertible promissory notes held by Mr. Honig, (iii) 500,000 shares of common stock issuable upon exercise of outstanding warrants held by Roth 401K, and (iv) shares of common stock issuable upon conversion of outstanding convertible promissory notes held by Roth 401K, all of which have beneficial ownership limitations. The address for this shareholder is 555 South Federal Highway, #450, Boca Raton, FL 33432.  |
| (8) | Information is based upon holdings reported on Schedule 13D filing and amendments, the most recent filed on January 10, 2017.  The address for this shareholder is 365 Bay St., Suite 840, Toronto, ON M5H 2V1, Canada.  Includes shares reported as beneficially owned by Mrs. DeFrancesco and held by DSB Capital, Ltd., a Turks & Caicos company where Ms. DeFrancesco serves as Trustee (75,000 shares), DeFrancesco Motorsports, Inc., an Ontario corporation where Ms. DeFrancesco serves as President (59,701 shares), Delavalco Holdings, Inc., an Ontario corporation where Ms. DeFrancesco serves as President (112,000 shares), Delavalco Holdings, Inc., a Florida corporation where Ms. DeFrancesco serves as President (85,466 shares), Marcandy Investments Corp., an Ontario corporation where Ms. DeFrancesco serves as President (85,000 shares), and Namaste Gorgie, Inc., an Ontario corporation where Ms. DeFrancesco serves as President (98,610 shares).                                |
| (9) | Information is based upon holdings reported on a Schedule 13G filed on February 10, 2017 by E. Jeffrey Peierls and Brian Eliot Peierls.  Brian Eliot Peierls may be deemed the beneficial owner of securities held by trusts of which Brian Eliot Peierls is a fiduciary. E. Jeffrey Peierls and Brian Eliot Peierls may be deemed to share indirect beneficial ownership of securities held by The Peierls Foundation, Inc. The address for the shareholder is 73 South Holman Way, Golden, CO 80401.  Includes (i) 273,742 shares of common stock and (ii) 5,002 shares of common stock issuable upon exercise of warrants. Also includes 48,231 shares of common stock and warrants exercisable to purchase 2,084 shares of common stock owned by The Peierls Foundation, Inc. as to which Mr. Peierls disclaims beneficial ownership for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended.                                                                                        |

----

|  Plan Category                |   | Number of securities to be issued upon exercise of outstanding options |    |   | Weighted average exercise price of outstanding options |   |    | Number of securities remaining available for future issuance |   |
|------------------------------------|--------|------------------------------------------------------------------------|---------|--------|--------------------------------------------------------|--------|---------|--------------------------------------------------------------|--------|
|                               |   |                                                                   |    |   |                                                   |   |    |                                                         |   |
| Equity compensation plans approved |   |                                                                   |    |   |                                                   |   |    |                                                         |   |
|  by security holders          |   |                                                                   | 566,747 |   |                                                   | $      | 20.46   |                                                         |   |   | 328,253 |   |
|                               |   |                                                                   |    |   |                                                   |   |    |                                                         |   |   |   |   |
| Equity compensation plans not      |   |                                                                   |    |   |                                                   |   |    |                                                         |   |   |   |   |
|  approved by security holders |   |                                                                   | — |   |                                                   |   | — |                                                         |   |   | — |   |
|                               |   |                                                                   |    |   |                                                   |   |    |                                                         |   |   |   |   |
| Total                              |   |                                                                   | 566,747 |   |                                                   | $      | 20.46   |                                                         |   |   | 328,253 |   |

----

|               |   | 2016   |    |   | 2015   |   |
|--------------------|--------|--------|---------|--------|--------|--------|
|               |   |   |    |   |   |   |
| Audit Fees         |   | $      | 87,000  |   |   | $      | 53,000 |   |
| Audit Related Fees |   |   | — |   |   |   | — |   |
| Tax Fees           |   |   | — |   |   |   | — |   |
| All Other Fees     |   |   | — |   |   |   | — |   |
| Total Fees         |   | $      | 87,000  |   |   | $      | 53,000 |   |

----

| ITEM 15. | EXHIBITS, FINANCIAL STATEMENT SCHEDULES. |
|----------|------------------------------------------|
| No.   |   | Exhibit                                                                                                                                                                                         |
|-------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1* |   | Certification of Principal Executive Officer pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                |
| 31.2* |   | Certification of Principal Financial Officer pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                |
| 32.1* |   | Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| * | Filed herewith. |
|---|-----------------|

----

|   | BIOPTIX, INC.                                                                                              |
|--------|------------------------------------------------------------------------------------------------------------|
|   |                                                                                                       |
|   | /s/ Michael M. Beeghley                                                                               |
|   | Michael M. Beeghley,Chief Executive Officer (principal executive officer)                                  |
|   |                                                                                                       |
|   | /s/ Jeffrey G. McGonegal                                                                                   |
|   | Jeffrey G. McGonegal,Chief Financial Officer (principal financial officer and principal accounting officer |

|   |                                                                                                         |   |           |
|--------|--------------------------------------------------------------------------------------------------------------|--------|----------------|
|   | /s/ Michael M. Beeghley                                                                                      |   | April 27, 2017 |
|   | Michael M. Beeghley,Chief Executive Officer, Chairman and Director (principal executive officer)             |   |           |
|   |                                                                                                         |   |           |
|   | /s/ Jeffrey G. McGonegal                                                                                     |   | April 27, 2017 |
|   | Jeffrey G. McGonegal, Chief Financial Officer (principal financial officer and principal accounting officer) |   |           |
|   |                                                                                                         |   |           |
|   | /s/ John R. O'Rourke                                                                                         |   | April 27, 2017 |
|   | John R. O'Rourke, Director                                                                                   |   |           |
|   |                                                                                                         |   |           |
|   | /s/ Mike Dai                                                                                                 |   | April 27, 2017 |
|   | Mike Dai, Director                                                                                           |   |           |
|   |                                                                                                         |   |           |
|   |                                                                                                         |   |           |

----